Aurantio-obtusin β-D-glucoside
CAS : 129025-96-3
Ref. 3D-EFA02596
10mg | À demander | ||
25mg | À demander | ||
50mg | À demander |
Informations sur le produit
- Glucoaurantio-obtusin
- 9,10-Anthracenedione, 3-(β-D-glucopyranosyloxy)-1,7-dihydroxy-2,8-dimethoxy-6-methyl-
- 3-(β-D-Glucopyranosyloxy)-1,7-dihydroxy-2,8-dimethoxy-6-methyl-9,10-anthracenedione
Aurantio-obtusin β-D-glucoside (AOBG) is a natural product that has been shown to have anti-cancer properties. It can inhibit the binding of the radioactive isotope, sn-38, to DNA and thus inactivates its cytotoxic activity. AOBG has been shown to be safe in clinical trials and does not affect the pharmacokinetics of other drugs. AOBG also inhibits the interaction between chemotherapeutic drugs and their targets, which is an important factor for drug resistance. This compound is a noncompetitive inhibitor that binds to a specific site on the enzyme's active site, preventing substrate binding and enzyme catalysis.
Propriétés chimiques
Question d’ordre technique sur : 3D-EFA02596 Aurantio-obtusin β-D-glucoside
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages